APPLICATIONS OF LONG-READ SEQUENCING IN CLINICAL GENOMICS
Dr Ira Deveson,
Laboratory Head
Genomic Technologies Research Lab,
Garvan Institute of Medical Research,
Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | October 2026
Dr Ira Deveson is a mid-career researcher and Snow Fellow. He has expertise in clinical genomics, biotechnology development and bioinformatics, with his lab focusing on applications of long-read sequencing in clinical genomics. His work spans from computational methods development and software/hardware engineering, to large-scale genomic analysis of diverse cohorts in health and disease.
Dr Ira Deveson graduated with a Bachelor of Philosophy from the Australian National University in 2012. He completed a PhD at the Garvan Institute of Medical Research from 2014-2017, supervised by Prof John Mattick and Dr Tim Mercer. Dr Deveson’s PhD focused on genome/transcriptome research and bioinformatics, and earned him recognition with the JD Catcheside prize from the Genetics Society of Australasia.
Dr Deveson was appointed as Head of Garvan’s Genomic Technologies Lab in 2020 and has since been awarded multiple significant NHMRC and MRFF grants to support his work on long-read sequencing technology development. He currently holds an NHMRC Investigator Grant (L1) and a prestigious Snow Medical Fellowship. His research has been published in leading science journals including Nature, Nature Biotechnology and Nature Methods. In addition to his research role, Dr Deveson leads the Long-read Sequencing Hub within Garvan’s Genomics Platform.
Source: Supplied
https://orcid.org/0000-0003-3861-0472
-
Biopsychosocial approaches to obsessive-compulsive, body image and eating disorders
Dr Nicola Acevedo is a Neuroscientist and Research Fellow with extensive expertise in developing novel therapeutics for neurological and psychiatric disorders, contributing to more than ten clinical trials. She specialises in brain stimulation and psychedelic treatments for obsessive-compulsive disorder (OCD) and related conditions, with a strong commitment to advancing personalised, evidence-based neurobiological therapies for severe psychiatric illness. Her approach integrates biopsychosocial and person-centred principles to improve treatment access and mental health outcomes.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
-
Dr Kelly-Anne Masterman
RESEARCH IN BRAIN COMPUTER INTERFACE
@ SYNCHRON
MELBOURNE, VICTORIA, AUSTRALIA
